Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry
Author:
Funder
Novartis
Amryt Pharma
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference33 articles.
1. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study;Roth;J. Am. Coll. Cardiol.,2020
2. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study;Yusuf;Lancet,2020
3. Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials;Guedeney;Eur. Heart J.,2019
4. Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials;Karatasakis;J. Am. Heart Assoc.,2017
5. Effects of Evolocumab on Low‐Density Lipoprotein Cholesterol, Non–High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta‐Analysis of Individual Participant Data From Double‐Blind and Open‐Label Extension Studies
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review;Pharmaceuticals;2024-07-09
2. Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk;Medicina Clínica;2024-07
3. Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations;Current Opinion in Lipidology;2024-03-27
4. Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis;Biology of Sex Differences;2024-03-26
5. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review;Journal of Clinical Medicine;2024-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3